Table 3.

Compliance Data, safety Assessment and Rescue Medication Usage

Compliance	Treatment Group A	Treatment Group B	Control Group	P
Participants received at least 20-session treatment in Group H (24 sessions in total, compliance rates > 80%)	34	31	28
Compliance data, No.(%)
Low	1(2.86%)	3(8.82%)	7(20.00%)
High	34(97.14%)	31(91.18%)	28(80.00%)	0.182
Safety assessment, No.(%)
Total adverse events	2	3	3	1.000
Severe adverse events	0(0.00%)	0(0.00%)	0(0.00%)
Subcutaneous hematoma	1(50.00%)	1(33.33%)	2(66.67%)
Subcutaneous hemorrhage	1(50.00%)	2(66.67%)	1(33.33%)
Rash	0(0.00%)	0(0.00%)	0(0.00%)
Rescue medication usage (Ibuprofen), No.(%)	6(17.14%)	5(14.71%)	5(14.29%)	1.000

Note: Adverse events were analyzed in participants who received treatment at least once.